Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma

Maria Luisa Palacios-Berraquero; Paula Rodriguez-Marquez; Maria Erendira Calleja-Cervantes; Nerea Berastegi; Aintzane Zabaleta; Leire Burgos; Diego Alignani; Patxi San Martin-Uriz; Amaia Vilas-Zornoza; Saray Rodriguez-Diaz; Susana Inoges; Ascensión Lopez-Diaz de Cerio; Sofia Huerga; Esteban Tamariz; Jose Rifón; Ana Alfonso-Pierola; Juan Jose Lasarte; Bruno Paiva; Mikel Hernaez; Paula Rodriguez-Otero; Jesus San Miguel; Teresa Ezponda; Juan Roberto Rodriguez-Madoz; Felipe Prosper

doi:10.1101/2024.05.22.24307750

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma

Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes, Nerea Berastegi, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Susana Inoges, Ascensión Lopez-Diaz de Cerio, Sofia Huerga, Esteban Tamariz, Jose Rifón, Ana Alfonso-Pierola, Juan Jose Lasarte, Bruno Paiva, Mikel Hernaez, Paula Rodriguez-Otero, Jesus San Miguel, Teresa Ezponda, Juan Roberto Rodriguez-Madoz, Felipe Prosper

doi: https://doi.org/10.1101/2024.05.22.24307750

Maria Luisa Palacios-Berraquero

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paula Rodriguez-Marquez

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Erendira Calleja-Cervantes

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

3Computational Biology Program. Cima Universidad de Navarra. IdiSNA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nerea Berastegi

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aintzane Zabaleta

4Flow Cytometry Core. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leire Burgos

4Flow Cytometry Core. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Diego Alignani

4Flow Cytometry Core. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patxi San Martin-Uriz

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amaia Vilas-Zornoza

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Saray Rodriguez-Diaz

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Susana Inoges

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

5Immunology and Immunotherapy Department. Clinica Universidad de Navarra (CUN)

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ascensión Lopez-Diaz de Cerio

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

5Immunology and Immunotherapy Department. Clinica Universidad de Navarra (CUN)

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sofia Huerga

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Esteban Tamariz

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jose Rifón

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ana Alfonso-Pierola

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Juan Jose Lasarte

6Immunology and Immunotherapy Program. Cima Universidad de Navarra. IdiSNA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bruno Paiva

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

4Flow Cytometry Core. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mikel Hernaez

3Computational Biology Program. Cima Universidad de Navarra. IdiSNA

7Data Science and Artificial Intelligence Institute (DATAI). Universidad de Navarra

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paula Rodriguez-Otero

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jesus San Miguel

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Teresa Ezponda

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: tezponda{at}unav.es jrrodriguez{at}unav.es fprosper{at}unav.es

Juan Roberto Rodriguez-Madoz

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: tezponda{at}unav.es jrrodriguez{at}unav.es fprosper{at}unav.es

Felipe Prosper

1Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA

2Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA

8Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: tezponda{at}unav.es jrrodriguez{at}unav.es fprosper{at}unav.es

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. The scRNA-seq data generated in this study have been deposited in the GEO database (GSE250444).